MetLife Investment Management’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-265
| Closed | -$176K | – | 2945 |
|
|
2023
Q1 | $176K | Buy |
265
+61
| +30% | +$40.6K | ﹤0.01% | 2293 |
|
|
2022
Q4 | $179K | Sell |
204
-52
| -20% | -$45.6K | ﹤0.01% | 2315 |
|
|
2022
Q3 | $282K | Hold |
256
| – | – | ﹤0.01% | 2068 |
|
|
2022
Q2 | $212K | Buy |
256
+76
| +42% | +$63.1K | ﹤0.01% | 2274 |
|
|
2022
Q1 | $278K | Buy |
180
+6
| +3% | +$9.28K | ﹤0.01% | 2138 |
|
|
2021
Q4 | $311K | Buy |
174
+29
| +20% | +$51.9K | ﹤0.01% | 1792 |
|
|
2021
Q3 | $477K | Sell |
145
-25
| -15% | -$82.2K | ﹤0.01% | 1547 |
|
|
2021
Q2 | $750K | Buy |
+170
| New | +$750K | 0.01% | 1337 |
|